KR102093096B1 - 재조합 펩타이드의 제조 방법 및 생성된 펩타이드 - Google Patents

재조합 펩타이드의 제조 방법 및 생성된 펩타이드 Download PDF

Info

Publication number
KR102093096B1
KR102093096B1 KR1020147030301A KR20147030301A KR102093096B1 KR 102093096 B1 KR102093096 B1 KR 102093096B1 KR 1020147030301 A KR1020147030301 A KR 1020147030301A KR 20147030301 A KR20147030301 A KR 20147030301A KR 102093096 B1 KR102093096 B1 KR 102093096B1
Authority
KR
South Korea
Prior art keywords
prt
artificial sequence
synthetic peptide
thr lys
lys pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147030301A
Other languages
English (en)
Korean (ko)
Other versions
KR20160001591A (ko
Inventor
니콜라이 페도로비치 먀소에도프
류드밀라 알렉산드로브나 안드레예바
드미트리 빅토로비치 골리코프
Original Assignee
“이빅스” 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by “이빅스” 리미티드 filed Critical “이빅스” 리미티드
Priority claimed from PCT/RU2013/000433 external-priority patent/WO2013151467A2/ru
Publication of KR20160001591A publication Critical patent/KR20160001591A/ko
Application granted granted Critical
Publication of KR102093096B1 publication Critical patent/KR102093096B1/ko
Assigned to 오브이비 (아일랜드) 리미티드 reassignment 오브이비 (아일랜드) 리미티드 권리의 전부이전등록 Assignors: “이빅스” 리미티드
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020147030301A 2013-05-28 2013-05-28 재조합 펩타이드의 제조 방법 및 생성된 펩타이드 Expired - Fee Related KR102093096B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2013/000433 WO2013151467A2 (ru) 2012-03-28 2013-05-28 Способ получения рекомбинантного пептида и полученный пептид

Publications (2)

Publication Number Publication Date
KR20160001591A KR20160001591A (ko) 2016-01-06
KR102093096B1 true KR102093096B1 (ko) 2020-03-25

Family

ID=53267175

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147030301A Expired - Fee Related KR102093096B1 (ko) 2013-05-28 2013-05-28 재조합 펩타이드의 제조 방법 및 생성된 펩타이드

Country Status (3)

Country Link
JP (1) JP6552960B2 (https=)
KR (1) KR102093096B1 (https=)
CN (2) CN104662034B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2655763C2 (ru) * 2016-10-24 2018-05-29 Общество С Ограниченной Ответственностью "Айвикс" Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции
JP2018118973A (ja) * 2018-02-23 2018-08-02 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． 組換えペプチドを生産するための方法および得られるペプチド

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009033678A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a tuftsin as a therapeutic agent
WO2010140926A1 (ru) * 2009-06-04 2010-12-09 Общество С Ограниченной Ответственностью "Био Пептид" Стимулятор половой, сексуальной и репродуктивной функции

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US6177405B1 (en) * 1992-07-22 2001-01-23 Kenji Nishioka Cyclic analogs of tuftsin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009033678A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a tuftsin as a therapeutic agent
WO2010140926A1 (ru) * 2009-06-04 2010-12-09 Общество С Ограниченной Ответственностью "Био Пептид" Стимулятор половой, сексуальной и репродуктивной функции

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ann. Neurol., Vol. 54, pp. 655-664(2003.)

Also Published As

Publication number Publication date
CN104662034A (zh) 2015-05-27
CN113413456A (zh) 2021-09-21
JP6552960B2 (ja) 2019-07-31
KR20160001591A (ko) 2016-01-06
JP2015515855A (ja) 2015-06-04
CN104662034B (zh) 2021-05-11

Similar Documents

Publication Publication Date Title
US8207122B2 (en) Anti-cancer bioactive peptides isolated from crude venom of Xinjiang Lycosa singoriensis
Schaffer et al. The fruitfly Drosophila melanogaster contains a novel charged adipokinetic-hormone-family peptide
US20170158735A1 (en) Method for producing a recombinant peptide and resultant peptide
JP2000500497A (ja) コラーゲン様ペプトイド残基含有構造物
KR102093096B1 (ko) 재조합 펩타이드의 제조 방법 및 생성된 펩타이드
CA2524722A1 (en) Acylated nonadepsipeptides
CN1876676A (zh) 抗肿瘤寡肽及其制备方法和应用
CA2602070A1 (en) Cyclic nonapeptide amides
JP4410100B2 (ja) 抗微生物性を有するペプチド、及びそれらを含む、特に食品保存用の組成物
Martynova et al. Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors
JP6858227B2 (ja) 組換えペプチドを生産するための方法および得られるペプチド
JP2018118973A (ja) 組換えペプチドを生産するための方法および得られるペプチド
Shah et al. Solid-phase total synthesis of cyclic peptide brachystemin A and its immunomodulating activity
AU2017349979B2 (en) FoxP3-binding peptides and uses thereof
RU2087480C1 (ru) Производные пептидов и способ их получения
RU2084458C1 (ru) Декапептид, обладающий противоопухолевой активностью
SU939440A1 (ru) Гептапептид в качестве стимул тора пам ти пролонгированного действи
RU2067870C1 (ru) Противоопухолевое средство
RU2411248C2 (ru) Средство, обладающее антипсихотической активностью
RU2442791C1 (ru) Способ получения бусерелина и промежуточные соединения для его получения
Tiwari et al. Synthesis and Characterization of Levofloxacin-Conjugated Amphiphilic Peptides
Grzywacz et al. Influence of N-and O-glycosylation on structural properties and biological activity of a C-terminal LL-37 fragment
RU2574392C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ТРИПЕПТИДА ОБЩЕЙ ФОРМУЛЫ (I) HPyr-His-TrpOH, ИСПОЛЬЗУЕМОГО В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО СОЕДИНЕНИЯ (1-3 ФРАГМЕНТА) В СИНТЕЗЕ СИНТЕТИЧЕСКИХ АГОНИСТОВ ГОНАДОТРОПИН-РИЛИЗИНГ-ГОРМОНА (LH-RH), МЕТОДОМ ЖИДКОФАЗНОГО ПЕПТИДНОГО СИНТЕЗА БЕЗ ПОСТАНОВКИ И СНЯТИЙ ЗАЩИТНЫХ ГРУПП
RU2340626C1 (ru) Способ получения додекапептида и трипептид для его осуществления
Fonina et al. Synthesis and Properties of the retro-Analogue of Myelopeptide MP-2

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0801 Dismissal of amendment

St.27 status event code: A-2-2-P10-P12-nap-PE0801

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20250320

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20250320

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20250320